Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2019 16:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Third Quarter 2019 Results on Monday November 4th, 2019

BUENA, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 4:30pm ET on...
October 28, 2019 23:46 ET | Source: Teligent, Inc.

Teligent Announces the Pricing of $34.4 Million of Series B Senior Convertible Notes

BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the pricing of...
October 28, 2019 14:16 ET | Source: Teligent, Inc.

Teligent Announces First Injectable Filing From New Manufacturing Facility

BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has filed a prior approval...
October 18, 2019 15:02 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Gentamicin Sulfate Cream USP, 0.1% (Gentamicin Base)

BUENA, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
October 01, 2019 16:15 ET | Source: Teligent, Inc.

Teligent Announces Strategic Review

BUENA, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Teligent Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has retained SVB Leerink as its...
August 05, 2019 16:15 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Second Quarter 2019 Results

BUENA, N.J., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second...
August 01, 2019 11:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Second Quarter 2019 Results on Monday August 5th, 2019

BUENA, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
June 18, 2019 16:27 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at the Raymond James Life Sciences and MedTech Conference on June 19th 2019

BUENA, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James Life Sciences and...
June 18, 2019 11:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at the Raymond James Life Sciences and MedTech Conference on June 19th 2019

BUENA, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James Life Sciences and...
May 06, 2019 16:15 ET | Source: Teligent, Inc.

Teligent, Inc. Announces First Quarter 2019 Results

BUENA, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter...